These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 23684136)
1. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts. Lin ZY; Chuang WL Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136 [TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells. Lin ZY; Chuang YH; Chuang WL Biomed Pharmacother; 2012 Oct; 66(7):525-9. PubMed ID: 22739041 [TBL] [Abstract][Full Text] [Related]
3. Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma. Lin ZY; Wu CC; Chuang YH; Chuang WL Life Sci; 2013 Sep; 93(8):323-8. PubMed ID: 23871804 [TBL] [Abstract][Full Text] [Related]
4. High therapeutic concentration of prazosin up-regulates angiogenic IL6 and CCL2 genes in hepatocellular carcinoma cells. Lin ZY; Chuang WL Biomed Pharmacother; 2012 Dec; 66(8):583-6. PubMed ID: 23089469 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic concentrations of ascorbic acid cause diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines. Lin ZY; Chuang WL Biomed Pharmacother; 2010 May; 64(5):348-51. PubMed ID: 19932582 [TBL] [Abstract][Full Text] [Related]
7. Pharmacologic concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines. Lin ZY; Chuang WL Biomed Pharmacother; 2010 Dec; 64(10):659-62. PubMed ID: 20970952 [TBL] [Abstract][Full Text] [Related]
8. Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells. Lin ZY; Chuang WL Biomed Pharmacother; 2012 Sep; 66(6):454-8. PubMed ID: 22681909 [TBL] [Abstract][Full Text] [Related]
9. [Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts]. Zeng Z; Hu P; Tang X; Zhang H; Du Y; Wen S; Liu M Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1071-5. PubMed ID: 25270211 [TBL] [Abstract][Full Text] [Related]
10. Contrary influence of clinically applied sorafenib concentrations among hepatocellular carcinoma patients. Lin ZY; Chuang WL Biomed Pharmacother; 2017 Feb; 86():27-31. PubMed ID: 27936391 [TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma. Mano Y; Yoshio S; Shoji H; Tomonari S; Aoki Y; Aoyanagi N; Okamoto T; Matsuura Y; Osawa Y; Kimura K; Yugawa K; Wang H; Oda Y; Yoshizumi T; Maehara Y; Kanto T J Gastroenterol; 2019 Nov; 54(11):1007-1018. PubMed ID: 30941514 [TBL] [Abstract][Full Text] [Related]
12. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma. Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374 [TBL] [Abstract][Full Text] [Related]
13. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature. Herrera M; Islam AB; Herrera A; Martín P; García V; Silva J; Garcia JM; Salas C; Casal I; de Herreros AG; Bonilla F; Peña C Clin Cancer Res; 2013 Nov; 19(21):5914-26. PubMed ID: 24052018 [TBL] [Abstract][Full Text] [Related]
14. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874 [TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways. Liu J; Chen S; Wang W; Ning BF; Chen F; Shen W; Ding J; Chen W; Xie WF; Zhang X Cancer Lett; 2016 Aug; 379(1):49-59. PubMed ID: 27216982 [TBL] [Abstract][Full Text] [Related]
16. FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells. Luo Q; Wang CQ; Yang LY; Gao XM; Sun HT; Zhang Y; Zhang KL; Zhu Y; Zheng Y; Sheng YY; Lu L; Jia HL; Yu WQ; Liu J; Dong QZ; Qin LX Cancer Lett; 2018 Mar; 417():21-34. PubMed ID: 29248714 [TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts-derived exosomal ZNF250 promotes the proliferation, migration, invasion, and immune escape of hepatocellular carcinoma cells by transcriptionally activating PD-L1. Feng H; Liu J; Jia H; Bu X; Yang W; Su P J Biochem Mol Toxicol; 2024 Sep; 38(9):e23778. PubMed ID: 39252517 [TBL] [Abstract][Full Text] [Related]
18. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation. Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819 [TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts promote the stemness of CD24 Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864 [TBL] [Abstract][Full Text] [Related]
20. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP. Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]